688799 华纳药厂
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)8.78712.73011.88615.00723.849
总资产报酬率 ROA (%)6.95210.0979.60511.82616.364
投入资产回报率 ROIC (%)8.12912.04411.34314.50523.514

边际利润分析
销售毛利率 (%)62.34264.78567.71272.38573.122
营业利润率 (%)15.29416.54915.16315.86416.923
息税前利润/营业总收入 (%)14.04115.18414.49415.35617.247
净利润/营业总收入 (%)13.03113.47313.41314.02115.256

收益指标分析
经营活动净收益/利润总额(%)88.66996.90293.02291.01694.325
价值变动净收益/利润总额(%)-6.9751.5594.0910.948-3.826
营业外收支净额/利润总额(%)-0.056-3.147-0.534-1.0342.190

偿债能力分析
流动比率 (X)4.4624.0134.2344.6461.892
速动比率 (X)3.1842.9343.0833.4881.051
资产负债率 (%)19.84918.77417.43917.69528.017
带息债务/全部投入资本 (%)6.8912.3762.068-0.114-2.603
股东权益/带息债务 (%)1,315.7393,980.9374,575.411-84,720.728-3,743.883
股东权益/负债合计 (%)398.376421.701455.722465.140256.925
利息保障倍数 (X)-11.291-17.654-24.640-44.472-310.105

营运能力分析
应收账款周转天数 (天)40.22239.24738.76236.98037.531
存货周转天数 (天)263.308250.413275.918277.521267.127